Saad Z. Usmani, MD, FACP

Division Chief, Plasma Cell Disorders Division
Director, Clinical Research in Hematologic Malignancies
Department of Hematologic Oncology & Blood Disorders
Levine Cancer Institute
Charlotte, North Carolina

Dr. Saad Usmani received his medical education at Allama Iqbal Medical College Lahore, Pakistan. He completed a residency in internal medicine at Sinai-Grace Hospital/Wayne State University in Detroit, Michigan, and a fellowship in hematology and oncology at the University of Connecticut Health Center in Farmington, Connecticut. Dr. Usmani joined the Levine Cancer Institute faculty in July 2013; he also currently holds an academic appointment as Clinical Professor of Medicine at the University of North Carolina-Chapel Hill School of Medicine.

Dr. Usmani is board certified in internal medicine, medical oncology, and hematology, and is a fellow of the American College of Physicians. He holds membership in several professional societies, including the International Myeloma Working Group (IMWG), SWOG Myeloma Committee, American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), and the American Society of Bone Marrow Transplantation (ASBMT). Dr. Usmani has served as the Track Leader on the ASCO Scientific Committee on Lymphoma and Plasma Cell Disorders, and he is a member of the ASH Committee on Plasma Cell Neoplasia and the National Cancer Institute Myeloma Steering Committee. He is on the editorial review board of numerous medical journals, and has authored/co-authored more than 150 peer-reviewed research manuscripts and 200 abstracts at national and international meetings. Active in clinical and translational research, Dr. Usmani’s research interests focus on plasma cell disorders—in particular, high-risk multiple myeloma.

Last modified: November 17, 2020